<VariationArchive RecordType="classified" VariationID="162495" VariationName="NM_000318.3(PEX2):c.865dup (p.Ser289fs)" VariationType="Duplication" Accession="VCV000162495" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-03-10" MostRecentSubmission="2017-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="172169" VariationID="162495">
      <GeneList>
        <Gene Symbol="PEX2" FullName="peroxisomal biogenesis factor 2" GeneID="5828" HGNC_ID="HGNC:9717" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q21.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="76980258" stop="77001044" display_start="76980258" display_stop="77001044" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="77892493" stop="77913279" display_start="77892493" display_stop="77913279" Strand="-" />
          </Location>
          <OMIM>170993</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000318.3(PEX2):c.865dup (p.Ser289fs)</Name>
      <CanonicalSPDI>NC_000008.11:76983313:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q21.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="76983313" stop="76983314" display_start="76983313" display_stop="76983314" variantLength="1" positionVCF="76983313" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="77895549" stop="77895550" display_start="77895549" display_stop="77895550" variantLength="1" positionVCF="77895549" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>S289fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.77895550dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.77895550dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.76983314dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.76983314dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008371.1" sequenceAccession="NG_008371" sequenceVersion="1" change="g.21975dup">
            <Expression>NG_008371.1:g.21975dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000318.3" sequenceAccession="NM_000318" sequenceVersion="3" change="c.865dup" MANESelect="true">
            <Expression>NM_000318.3:c.865dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000309.2" sequenceAccession="NP_000309" sequenceVersion="2" change="p.Ser289fs">
            <Expression>NP_000309.2:p.Ser289fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079867.2" sequenceAccession="NM_001079867" sequenceVersion="2" change="c.865dup">
            <Expression>NM_001079867.2:c.865dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073336.2" sequenceAccession="NP_001073336" sequenceVersion="2" change="p.Ser289fs">
            <Expression>NP_001073336.2:p.Ser289fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172086.2" sequenceAccession="NM_001172086" sequenceVersion="2" change="c.865dup">
            <Expression>NM_001172086.2:c.865dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165557.2" sequenceAccession="NP_001165557" sequenceVersion="2" change="p.Ser289fs">
            <Expression>NP_001165557.2:p.Ser289fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172087.2" sequenceAccession="NM_001172087" sequenceVersion="2" change="c.865dup">
            <Expression>NM_001172087.2:c.865dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165558.2" sequenceAccession="NP_001165558" sequenceVersion="2" change="p.Ser289fs">
            <Expression>NP_001165558.2:p.Ser289fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA175083" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="170993.0006" DB="OMIM" />
        <XRef Type="rs" ID="724160029" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000318.3(PEX2):c.865dup (p.Ser289fs) AND Peroxisome biogenesis disorder 5B" Accession="RCV000149879" Version="4">
        <ClassifiedConditionList TraitSetID="8952">
          <ClassifiedCondition DB="MedGen" ID="C3542026">Peroxisome biogenesis disorder 5B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-03-10" MostRecentSubmission="2017-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21392394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23430938</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8952" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17433" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 5B</ElementValue>
                <XRef ID="MONDO:0013933" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD5B</ElementValue>
                <XRef Type="MIM" ID="614867" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).
For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.
Individuals with mutations in the PEX2 gene have cells of complementation group 5 (CG5, equivalent to CG10 and CGF). For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614867" DB="OMIM" />
              </AttributeSet>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C3542026" DB="MedGen" />
              <XRef ID="MONDO:0013933" DB="MONDO" />
              <XRef Type="MIM" ID="614867" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="354474" SubmissionDate="2017-03-06" DateLastUpdated="2017-03-10" DateCreated="2015-01-18">
        <ClinVarSubmissionID localKey="170993.0006_PEROXISOME BIOGENESIS DISORDER 5B" title="PEX2, 1-BP INS, 865A_PEROXISOME BIOGENESIS DISORDER 5B" />
        <ClinVarAccession Accession="SCV000196733" DateUpdated="2017-03-10" DateCreated="2015-01-18" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 brothers, born of unrelated parents, with PBD5B (614867) manifest as isolated cerebellar ataxia beginning in the first or second decade, Sevin et al. (2011) identified a homozygous 1-bp insertion (c.865_866insA) in the PEX2 gene, resulting in a frameshift and premature termination (Ser289LysfsTer36). The patient's unaffected mother was heterozygous for the mutation and 2 unaffected sisters did not carry the mutation; paternal DNA was not available. The mutation was not present in a control database. Patient fibroblasts showed normal peroxisomes and contained catalase, suggesting that the mutant protein is localized correctly in the peroxisomal membrane and retains some activity. Further functional studies were not performed. The report expanded the phenotypic spectrum associated with PEX2 mutations to include mild and isolated autosomal recessive cerebellar ataxia.</Attribute>
              <Citation>
                <ID Source="PubMed">21392394</ID>
              </Citation>
              <XRef DB="OMIM" ID="614867" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 51-year-old Italian man, born of unrelated parents, with PBD5B manifest as childhood-onset cerebellar ataxia and an axonal sensorimotor polyneuropathy, Mignarri et al. (2012) identified compound heterozygosity for the c.865_866insA mutation and an R119X mutation (170993.0001) in the PEX2 gene. Patient fibroblasts showed mosaicism for a peroxisomal defect, but further functional studies were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">23430938</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX2" />
          </GeneList>
          <Name>PEX2, 1-BP INS, 865A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 865A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="170993.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 5B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="354474" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 5B" MappingRef="Preferred">
        <MedGen CUI="C3542026" Name="Peroxisome biogenesis disorder 5B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

